ATE269080T1 - Mikrokapsel mit verzögerter freigabe für wasserlösliche arzneistoffe - Google Patents
Mikrokapsel mit verzögerter freigabe für wasserlösliche arzneistoffeInfo
- Publication number
- ATE269080T1 ATE269080T1 AT98113177T AT98113177T ATE269080T1 AT E269080 T1 ATE269080 T1 AT E269080T1 AT 98113177 T AT98113177 T AT 98113177T AT 98113177 T AT98113177 T AT 98113177T AT E269080 T1 ATE269080 T1 AT E269080T1
- Authority
- AT
- Austria
- Prior art keywords
- water soluble
- delayed release
- soluble drugs
- release micro
- micro capsule
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000003094 microcapsule Substances 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19030097 | 1997-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269080T1 true ATE269080T1 (de) | 2004-07-15 |
Family
ID=16255875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98113177T ATE269080T1 (de) | 1997-07-15 | 1998-07-15 | Mikrokapsel mit verzögerter freigabe für wasserlösliche arzneistoffe |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US6287587B2 (de) |
| EP (1) | EP0891774B1 (de) |
| AT (1) | ATE269080T1 (de) |
| CA (1) | CA2243201C (de) |
| DE (1) | DE69824491T2 (de) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4575592B2 (ja) | 1997-11-14 | 2010-11-04 | パシラ ファーマシューティカルズ インコーポレーテッド | 多小胞リポソームの製造 |
| AU1982599A (en) * | 1998-01-21 | 1999-08-09 | Takeda Chemical Industries Ltd. | Lyophilization method for sustained-release preparations |
| DE69904701T2 (de) | 1998-03-20 | 2003-11-06 | Takeda Chemical Industries, Ltd. | Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung |
| US6099859A (en) | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| WO2000003660A1 (en) | 1998-07-17 | 2000-01-27 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| IL140984A0 (en) † | 1998-07-23 | 2002-02-10 | Lilly Co Eli | Fsh and fsh variant formulations, products and methods |
| JP2001058955A (ja) * | 1999-06-17 | 2001-03-06 | Inst Of Physical & Chemical Res | 生理活性ペプチド徐放性製剤 |
| WO2001010463A1 (en) * | 1999-08-05 | 2001-02-15 | Takeda Chemical Industries, Ltd. | Pastes with the sustained release of osteogenesis promoter |
| WO2001097784A1 (en) * | 2000-06-23 | 2001-12-27 | Takeda Chemical Industries, Ltd. | Process for producing phospholipid-containing drugs |
| KR100392501B1 (ko) * | 2000-06-28 | 2003-07-22 | 동국제약 주식회사 | 다중 에멀젼법에 의한 서방출성 미립구의 제조방법 |
| US20030096000A1 (en) * | 2001-05-31 | 2003-05-22 | Solis Rosa Maria | Encapsulation of nanosuspensions in liposomes and microspheres |
| US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| US7732451B2 (en) * | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
| US7354923B2 (en) * | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| CA2462200A1 (en) * | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| EP1572933A4 (de) | 2002-02-13 | 2007-09-05 | Univ Duke | Modulation der immunantwort durch polypeptide als antwort auf nichtpeptidischen bindungsstress |
| EP2301573A1 (de) | 2002-10-01 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Zusammensetzungen gegen Krebs und Infektionskrankheiten und Anwendungsverfahren dafür |
| KR101096374B1 (ko) * | 2003-03-28 | 2011-12-20 | (주)아모레퍼시픽 | 폴리올/고분자 마이크로캡슐을 이용한 유효성분 안정화방법 및 이를 함유하는 화장료 조성물 |
| US7691296B2 (en) | 2002-11-25 | 2010-04-06 | Amorepacific Corporation | Method for stabilizing active components using polyol/polymer microcapsule, and cosmetic composition containing the microcapsule |
| JP4300346B2 (ja) * | 2002-12-18 | 2009-07-22 | 日産自動車株式会社 | 燃料電池システム |
| US6936273B2 (en) * | 2002-12-20 | 2005-08-30 | Idexx Laboratories, Inc. | Liposomal analgesic formulation and use |
| AU2003301174A1 (en) * | 2002-12-20 | 2004-07-22 | Idexx Laboratories, Inc. | Liposomal analgesic formulation and use |
| AU2004226666B9 (en) | 2003-04-02 | 2010-04-08 | Ares Trading S.A. | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant |
| US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
| US7968548B2 (en) | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
| AU2004248931B2 (en) | 2003-06-20 | 2009-07-16 | Ares Trading S.A. | Freeze-dried FSH / LH formulations |
| KR101087464B1 (ko) | 2003-08-08 | 2011-11-25 | 밸리언트 인터내셔널(바베이도스) 에스알엘 | 부프로피온 히드로클로라이드의 개질 방출형 정제 |
| US7015049B2 (en) * | 2003-09-03 | 2006-03-21 | Infineon Technologies Ag | Fence-free etching of iridium barrier having a steep taper angle |
| US20070014846A1 (en) * | 2003-10-10 | 2007-01-18 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| EP1680091B1 (de) | 2003-10-10 | 2017-05-31 | Veloxis Pharmaceuticals A/S | Feste dosierform mit einem fibrat |
| US20050096391A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and rosuvastatin |
| US20060068015A1 (en) * | 2003-10-10 | 2006-03-30 | Per Holm | Solid dosage form comprising a fibrate and a statin |
| US20050096390A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and pravastatin |
| US9173847B2 (en) * | 2003-10-10 | 2015-11-03 | Veloxis Pharmaceuticals A/S | Tablet comprising a fibrate |
| US9533330B2 (en) * | 2003-11-19 | 2017-01-03 | David Jonathan Tafoya | Removing soluble support material from rapid prototype part |
| US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| DK1742616T3 (en) * | 2004-04-30 | 2015-01-12 | Abraxis Bioscience Llc | The microsphere-discharge-system for the prolonged delivery and methods of making and using the same |
| WO2006132752A1 (en) * | 2005-05-10 | 2006-12-14 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising vitamin k2 |
| US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
| US20080107744A1 (en) * | 2006-11-06 | 2008-05-08 | Jack Fa-De Chu | Injectable hollow tissue filler |
| WO2009057808A1 (ja) * | 2007-11-02 | 2009-05-07 | Aspion Co., Ltd. | 難溶性薬物－界面活性剤複合体製品とその製造法 |
| USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
| JP5681626B2 (ja) | 2008-07-14 | 2015-03-11 | ポリーペイド リミテッドＰｏｌｙｐｉｄ Ｌｔｄ． | 徐放性薬剤キャリア組成物 |
| CA2730760A1 (en) * | 2008-07-16 | 2010-01-21 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles containing bioactive peptides |
| US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| CN102470105B (zh) | 2009-07-14 | 2015-07-29 | 波利皮得有限公司 | 持续释放药物载体组合物 |
| AU2011208374B2 (en) | 2010-01-19 | 2016-09-08 | Polypid Ltd. | Sustained-release nucleic acid matrix compositions |
| US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
| US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
| US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
| CN102120169A (zh) * | 2010-12-27 | 2011-07-13 | 河北联合大学 | 铁叶绿酸钠-壳聚糖/海藻酸钠微囊及制备方法 |
| CN104264469B (zh) * | 2014-09-16 | 2016-06-01 | 北京化工大学 | 外亲水内亲油或外亲油内亲水核壳纳米纤维的制备方法 |
| JP5938762B1 (ja) | 2015-09-01 | 2016-06-22 | 日揮株式会社 | マイクロカプセル製剤及びその製造方法 |
| US12151024B2 (en) | 2021-01-22 | 2024-11-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| GB2627096A (en) | 2021-10-14 | 2024-08-14 | Pacira Pharmaceuticals Inc | Bupivacaine multivesicular liposome formulations and uses thereof |
| CN117678705B (zh) * | 2024-01-15 | 2025-09-12 | 重庆市老川牛食品有限公司 | 一种麻辣味牛肉干的制备工艺 |
| US12251468B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12246092B1 (en) | 2024-05-20 | 2025-03-11 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251472B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6163613A (ja) | 1984-09-04 | 1986-04-01 | Mitsui Toatsu Chem Inc | 顆粒状に調整された徐放性製剤 |
| EP0190833B1 (de) * | 1985-02-07 | 1991-03-27 | Takeda Chemical Industries, Ltd. | Verfahren zur Herstellung von Mikrokapseln |
| US5271945A (en) * | 1988-07-05 | 1993-12-21 | Takeda Chemical Industries, Ltd. | Sustained release microcapsule for water soluble drug |
| DE69220317T2 (de) | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe |
| DE69519382T3 (de) | 1994-09-09 | 2008-09-18 | Takeda Pharmaceutical Co. Ltd. | Zubereitung mit verzögerter freigabe eines metallsalz eines peptids |
| US6117455A (en) | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
| EP0765660A3 (de) | 1995-09-28 | 1998-09-23 | Takeda Chemical Industries, Ltd. | Mikrokapseln enthaltend 2-Piperazinon-1-essigsäure Verbindungen |
| EP0889722B1 (de) | 1996-03-28 | 2002-11-20 | Takeda Chemical Industries, Ltd. | Zubereitung mit verzögerter freisetzung und deren herstellung |
-
1998
- 1998-07-09 US US09/112,317 patent/US6287587B2/en not_active Expired - Lifetime
- 1998-07-14 CA CA002243201A patent/CA2243201C/en not_active Expired - Fee Related
- 1998-07-15 EP EP98113177A patent/EP0891774B1/de not_active Expired - Lifetime
- 1998-07-15 AT AT98113177T patent/ATE269080T1/de not_active IP Right Cessation
- 1998-07-15 DE DE69824491T patent/DE69824491T2/de not_active Expired - Lifetime
-
2001
- 2001-04-20 US US09/838,232 patent/US20010018075A1/en not_active Abandoned
- 2001-10-05 US US09/971,039 patent/US20020037837A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20010014339A1 (en) | 2001-08-16 |
| US20020037837A1 (en) | 2002-03-28 |
| DE69824491T2 (de) | 2005-06-30 |
| CA2243201C (en) | 2009-06-16 |
| EP0891774A2 (de) | 1999-01-20 |
| US20010018075A1 (en) | 2001-08-30 |
| DE69824491D1 (de) | 2004-07-22 |
| US6287587B2 (en) | 2001-09-11 |
| EP0891774B1 (de) | 2004-06-16 |
| CA2243201A1 (en) | 1999-01-15 |
| EP0891774A3 (de) | 2000-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69824491D1 (de) | Mikrokapsel mit verzögerter Freigabe für wasserlösliche Arzneistoffe | |
| BR0208838A (pt) | Microencapsulação de um agente ativo agrìcola tendo um alto ponto de fusão | |
| TW200510003A (en) | Pharmaceutical composition of rapid disintegrating tablet and method of preparing the same | |
| ATE313375T1 (de) | Mikrokapseln | |
| KR920700762A (ko) | 향상된 피낭 제조 방법 및 그의 체형 | |
| ATE380541T1 (de) | Herstellung von vitaminemulsionen und konzentrate davon | |
| DK0862418T3 (da) | Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde | |
| BR9607752A (pt) | Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas | |
| EA200400087A1 (ru) | Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата | |
| FI973452A7 (fi) | Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen | |
| EA200400862A1 (ru) | Твёрдая лекарственная форма, содержащая сердцевинную таблетку с активным фармацевтическим ингредиентом, покрытую кольцеобразной оболочкой из спрессованного порошкообразного или гранулированного материала, способ приготовления такой лекарственной формы и устройство для её приготовления | |
| BR0005287A (pt) | Método para preparação de uma micropartìcula de liberação prolongada e micropartìcula de liberação prolongada assim obtida | |
| DK1343480T3 (da) | Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler | |
| ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| AU2386595A (en) | Aqueous solvent encapsulation method, apparatus and microcapsules | |
| AR034640A1 (es) | Composicion de liberacion sostenida y proceso para producirla | |
| ATE322250T1 (de) | Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen | |
| BR0109802A (pt) | Preparações farmacêuticas e sua fabricação | |
| CO4410175A1 (es) | Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion | |
| IE900651L (en) | Pharmaceutical Compositions | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| PT1194415E (pt) | Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
| FR2748209B1 (fr) | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs | |
| AR011682A1 (es) | UN MÉTODO PARA LA PREPARACIoN DE UNA COMPOSICIoN FARMACÉUTICA ACUOSA CON UN INGREDIENTE ACTIVO QUE TIENE UNA SOLUBILIDAD EN AGUA NO MAYOR QUE 0,01% (P/V) QUE ESTÁ DISPERSO EN LIPOSOMAS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |